Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Nutrient availability has a profound impact on cell fate. Upon nitrogen starvation, wild-type fission yeast cells uncouple cell growth from cell division to generate small, round-shaped cells that are competent for sexual differentiation. The TORC1 (TOR complex 1) and TORC2 complexes exert opposite controls on cell growth and cell differentiation, but little is known about how their activity is coordinated. We show that transfer RNA (tRNA) modifications by Elongator are critical for this regulation by promoting the translation of both key components of TORC2 and repressors of TORC1. We further identified the TORC2 pathway as an activator of Elongator by down-regulating a Gsk3 (glycogen synthase kinase 3)-dependent inhibitory phosphorylation of Elongator. Therefore, a feedback control is operating between TOR complex (TORC) signaling and tRNA modification by Elongator to enforce the advancement of mitosis that precedes cell differentiation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584457 | PMC |
| http://dx.doi.org/10.1126/sciadv.aav0184 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A calcium sensor kinase pathway interacts with the TOR complex to balance growth and salt tolerance in Arabidopsis.
Plant Cell
July 2025
Department of Plant and Microbial Biology, University of California, Berkeley, CA 94720, USA.
Soil salinity negatively affects crop yields worldwide. The dynamic transition between growth and salt stress responses helps plants cope with changing soil salinity status. However, the molecular mechanisms controlling such dynamic transitions remain poorly understood.
View Article and Find Full Text PDFPupylation-Based Proximity Labeling Unravels a Comprehensive Protein and Phosphoprotein Interactome of the Arabidopsis TOR Complex.
Adv Sci (Weinh)
May 2025
Copenhagen Plant Science Center (CPSC), Department of Plant & Environmental Sciences, University of Copenhagen, Frederiksberg C, 1871, Denmark.
Target of rapamycin (TOR) is a signaling hub that integrates developmental, hormonal, and environmental signals to optimize carbon allocation and plant growth. In plant cells, TOR acts together with the proteins LST8-1 and RAPTOR1 to form a core TOR complex (TORC). While these proteins comprise a functional TORC, they engage with many other proteins to ensure precise signal outputs.
View Article and Find Full Text PDFDrug Repurposing in Pancreatic Cancer: A Multi-Stakeholder Perspective to Improve Treatment Options for Pancreatic Cancer Patients.
Cancer Manag Res
March 2025
EURORDIS - Rare Diseases Europe, Paris, France.
Pancreatic cancer (PC) remains one of the most challenging malignancies to treat. Current therapeutic options are unsatisfactory, and there is an urgent need for more effective and less toxic drugs to improve the dismal prognosis of PC. In recent years, drug repurposing (DR) has emerged as an attractive strategy to identify novel treatments for PC by leveraging existing drugs approved for other indications.
View Article and Find Full Text PDFThe Regulatory-associated protein of target of rapamycin 1B (RAPTOR 1B) interconnects with the photoperiod pathway to promote flowering in .
Proc Natl Acad Sci U S A
February 2025
Max-Planck Institut für Molekulare Pflanzenphysiologie, Potsdam-Golm 14476, Germany.
The transition from vegetative to reproductive growth, or floral transition, is a tightly regulated, energy-demanding process. In , the interplay of light perception and circadian rhythms detects changes in photoperiod length, accelerating flowering under long days (LD). CONSTANS (CO), a transcription factor, upregulates FLOWERING LOCUS T (FT) in leaves during dusk.
View Article and Find Full Text PDFDisrupted Lipid Metabolism, Cytokine Signaling, and Dormancy: Hallmarks of Doxorubicin-Resistant Triple-Negative Breast Cancer Models.
Cancers (Basel)
December 2024
Translational Oncology Research Center (TORC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha P.O. Box 34110, Qatar.
Background: Chemoresistance in triple-negative breast cancer (TNBC) presents a significant clinical hurdle, limiting the efficacy of treatments like doxorubicin. This study aimed to explore the molecular changes associated with doxorubicin resistance and identify potential therapeutic targets to overcome this resistance, thereby improving treatment outcomes for TNBC patients.
Methods: Doxorubicin-resistant (DoxR) TNBC models (MDA-MB-231 and BT-549) were generated by exposing cells to increasing concentrations of doxorubicin.